LGN (LGN) Financials

LGN logo
$34.85 +0.67 (+1.96%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$35.75 +0.90 (+2.58%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for LGN

Annual Income Statements for LGN

This table shows LGN's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-46 -29 -60
Consolidated Net Income / (Loss)
-46 -28 -77
Net Income / (Loss) Continuing Operations
-46 -28 -77
Total Pre-Tax Income
-54 -23 -55
Total Operating Income
8.93 70 62
Total Gross Profit
315 431 536
Total Revenue
1,615 2,099 2,550
Operating Revenue
1,615 2,099 2,550
Total Cost of Revenue
1,300 1,668 2,015
Operating Cost of Revenue
1,300 1,668 2,015
Total Operating Expenses
306 363 476
Selling, General & Admin Expense
186 243 343
Depreciation Expense
80 97 100
Impairment Charge
5.05 18 27
Restructuring Charge
3.79 5.63 5.74
Other Special Charges / (Income)
31 0.00 -0.33
Total Other Income / (Expense), net
-63 -90 -115
Interest Expense
68 92 108
Interest & Investment Income
5.58 8.53 5.93
Other Income / (Expense), net
-0.26 -7.33 -13
Income Tax Expense
-7.92 4.52 22
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.91 -18
Basic Earnings per Share
$0.00 $0.00 $0.00
Weighted Average Basic Shares Outstanding
0.00 0.00 0.00
Diluted Earnings per Share
$0.00 $0.00 $0.00
Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00
Weighted Average Basic & Diluted Shares Outstanding
- - 108.04M

Quarterly Income Statements for LGN

This table shows LGN's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-1.08 -21 -5.27 -0.58 16 -28 90
Consolidated Net Income / (Loss)
-0.68 -19 -3.87 0.38 17 -35 134
Net Income / (Loss) Continuing Operations
-0.68 -19 -3.87 0.38 17 -35 134
Total Pre-Tax Income
3.89 -15 1.68 4.46 4.01 -23 154
Total Operating Income
27 17 31 37 22 -6.71 167
Total Gross Profit
119 112 129 148 186 220 275
Total Revenue
561 506 599 708 1,038 1,262 1,311
Operating Revenue
561 506 599 708 1,038 1,262 1,311
Total Cost of Revenue
442 394 470 560 852 1,042 1,035
Operating Cost of Revenue
442 394 470 560 852 1,042 1,035
Total Operating Expenses
93 96 98 111 164 227 108
Selling, General & Admin Expense
67 69 72 86 116 148 70
Depreciation Expense
25 26 25 24 37 38 38
Impairment Charge
- - 0.00 0.00 - 41 0.00
Restructuring Charge
0.15 0.16 0.02 0.80 11 0.42 0.50
Other Special Charges / (Income)
0.00 -0.10 -0.12 0.02 -0.06 -0.12 -0.12
Total Other Income / (Expense), net
-22 -31 -29 -33 -18 -17 -13
Interest Expense
24 30 30 34 17 17 16
Interest & Investment Income
1.76 1.22 1.13 1.09 1.82 2.00 2.62
Other Income / (Expense), net
0.12 -2.77 -0.01 0.06 -2.67 -1.85 0.51
Income Tax Expense
4.56 4.04 5.55 4.08 -13 11 20
Net Income / (Loss) Attributable to Noncontrolling Interest
0.41 2.07 1.40 0.96 1.30 -6.72 44
Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.24 ($0.37) $1.16
Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 0.00 67.15M 76.03M 76.93M
Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.13 ($0.37) $1.15
Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 0.00 108.43M 76.03M 77.81M
Weighted Average Basic & Diluted Shares Outstanding
- - - 105.34M 108.04M 108.08M 108.53M

Annual Cash Flow Statements for LGN

This table details how cash moves in and out of LGN's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
28 -7.75 149
Net Cash From Operating Activities
34 29 257
Net Cash From Continuing Operating Activities
34 29 257
Net Income / (Loss) Continuing Operations
-46 -28 -77
Consolidated Net Income / (Loss)
-46 -28 -77
Depreciation Expense
23 30 32
Amortization Expense
75 86 86
Non-Cash Adjustments To Reconcile Net Income
1.63 -13 53
Changes in Operating Assets and Liabilities, net
-20 -46 163
Net Cash From Investing Activities
-134 -244 -54
Net Cash From Continuing Investing Activities
-134 -244 -54
Purchase of Property, Plant & Equipment
-17 -19 -38
Acquisitions
-120 -225 -16
Sale of Property, Plant & Equipment
0.35 0.27 0.39
Sale and/or Maturity of Investments
2.70 0.00 0.00
Net Cash From Financing Activities
128 207 -54
Net Cash From Continuing Financing Activities
128 207 -54
Repayment of Debt
-18 -22 -862
Repurchase of Common Equity
0.00 -0.20 -28
Payment of Dividends
-1.53 -302 0.00
Issuance of Debt
155 565 60
Issuance of Common Equity
0.00 0.00 780
Other Financing Activities, net
-6.91 -35 -3.84

Quarterly Cash Flow Statements for LGN

This table details how cash moves in and out of LGN's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
1.86 7.96 8.77 78 54 14 47 49
Net Cash From Operating Activities
6.04 29 33 100 95 120 74 82
Net Cash From Continuing Operating Activities
6.04 29 33 100 95 120 74 82
Net Income / (Loss) Continuing Operations
-18 -19 -3.87 0.38 -55 17 -35 134
Consolidated Net Income / (Loss)
-18 -19 -3.87 0.38 -55 17 -35 134
Depreciation Expense
8.40 7.89 8.00 7.84 8.22 9.72 11 12
Amortization Expense
23 23 22 21 21 33 34 33
Non-Cash Adjustments To Reconcile Net Income
-27 -11 -2.26 7.51 59 21 93 -158
Changes in Operating Assets and Liabilities, net
20 29 9.46 63 61 39 -29 62
Net Cash From Investing Activities
-11 -5.75 -8.70 -11 -29 -299 -24 -18
Net Cash From Continuing Investing Activities
-11 -5.75 -8.70 -11 -29 -299 -24 -18
Purchase of Property, Plant & Equipment
-6.23 -5.36 -8.80 -11 -13 -18 -24 -18
Sale of Property, Plant & Equipment
0.08 0.07 0.10 0.06 0.16 0.13 0.09 0.11
Net Cash From Financing Activities
7.11 -16 -16 -11 -12 193 -3.10 -15
Net Cash From Continuing Financing Activities
7.51 -16 -16 -11 -12 193 -3.10 -15
Repayment of Debt
-7.01 -9.98 -5.09 -786 -61 -30 -1.53 -6.64
Other Financing Activities, net
-0.34 -0.85 -0.96 -0.88 -1.15 -1.29 -1.57 -4.80

Annual Balance Sheets for LGN

This table presents LGN's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2025
Period end date 12/31/2024 12/31/2025
Total Assets
2,353 2,679
Total Current Assets
756 1,110
Cash & Equivalents
81 230
Accounts Receivable
449 584
Prepaid Expenses
39 36
Other Current Assets
188 260
Plant, Property, & Equipment, net
73 0.00
Total Noncurrent Assets
1,523 1,569
Goodwill
781 764
Intangible Assets
624 551
Other Noncurrent Operating Assets
117 253
Total Liabilities & Shareholders' Equity
2,353 2,679
Total Liabilities
2,149 1,891
Total Current Liabilities
411 708
Short-Term Debt
23 17
Accounts Payable
127 246
Accrued Expenses
28 16
Current Employee Benefit Liabilities
55 68
Other Current Liabilities
14 361
Total Noncurrent Liabilities
1,738 1,182
Long-Term Debt
1,586 812
Noncurrent Deferred & Payable Income Tax Liabilities
35 47
Other Noncurrent Operating Liabilities
117 323
Commitments & Contingencies
0.00 0.00
Total Equity & Noncontrolling Interests
204 789
Total Preferred & Common Equity
0.00 392
Preferred Stock
0.00 0.00
Total Common Equity
203 392
Common Stock
444 703
Retained Earnings
-250 -310
Treasury Stock
- 0.00
Accumulated Other Comprehensive Income / (Loss)
9.11 -0.70
Noncontrolling Interest
0.91 397

Quarterly Balance Sheets for LGN

This table presents LGN's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
2,600 3,483 3,740 3,833
Total Current Assets
1,038 1,471 1,648 1,763
Cash & Equivalents
176 245 292 341
Accounts Receivable
588 827 919 842
Prepaid Expenses
39 43 55 67
Other Current Assets
234 356 382 513
Plant, Property, & Equipment, net
81 0.00 0.00 0.00
Total Noncurrent Assets
1,481 2,013 2,092 2,070
Goodwill
783 842 823 823
Intangible Assets
562 843 792 760
Other Noncurrent Operating Assets
136 327 477 488
Total Liabilities & Shareholders' Equity
2,600 3,483 3,740 3,833
Total Liabilities
1,773 2,532 2,762 2,761
Total Current Liabilities
660 1,133 1,225 1,225
Short-Term Debt
16 18 26 22
Accounts Payable
224 350 429 440
Accrued Expenses
26 74 81 93
Current Employee Benefit Liabilities
90 120 139 154
Other Current Liabilities
304 571 549 515
Total Noncurrent Liabilities
1,113 1,399 1,537 1,536
Long-Term Debt
813 1,009 1,008 1,007
Noncurrent Deferred & Payable Income Tax Liabilities
42 45 43 42
Other Noncurrent Operating Liabilities
259 345 486 486
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
827 951 978 1,072
Total Preferred & Common Equity
388 505 600 682
Preferred Stock
0.00 0.00 0.00 0.00
Total Common Equity
0.00 505 600 682
Common Stock
665 798 918 910
Retained Earnings
-277 -294 -322 -232
Treasury Stock
- - - -3.40
Accumulated Other Comprehensive Income / (Loss)
-0.25 1.22 4.07 7.79
Noncontrolling Interest
440 446 377 390

Annual Metrics And Ratios for LGN

This table displays calculated financial ratios and metrics derived from LGN's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 105,336,929.00
DEI Adjusted Shares Outstanding
0.00 0.00 105,336,929.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -0.57
Growth Metrics
- - -
Profitability Metrics
- - -
Net Operating Profit after Tax (NOPAT)
6.25 49 43
Return On Investment Capital (ROIC_SIMPLE)
- 2.72% 2.66%
Earnings before Interest and Taxes (EBIT)
8.67 63 49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
107 179 167
Valuation Ratios
- - -
Leverage & Solvency
- - -
Liquidity Ratios
- - -
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -1,682 387
Efficiency Ratios
- - -
Capital & Investment Metrics
- - -
Invested Capital
0.00 1,731 1,388
Increase / (Decrease) in Invested Capital
0.00 1,731 -344
Book Value per Share
$0.00 $7.80 $0.00
Tangible Book Value per Share
$0.00 ($46.26) ($12.49)
Total Capital
0.00 1,812 1,618
Total Debt
0.00 1,609 829
Total Long-Term Debt
0.00 1,586 812
Net Debt
0.00 1,528 599
Capital Expenditures (CapEx)
17 19 38
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 287 189
Debt-free Net Working Capital (DFNWC)
0.00 368 419
Net Working Capital (NWC)
0.00 345 402
Net Nonoperating Expense (NNE)
52 77 120
Net Nonoperating Obligations (NNO)
0.00 1,528 599
Total Depreciation and Amortization (D&A)
98 116 118
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 108.04M
Normalized Net Operating Profit after Tax (NOPAT)
34 66 66
Debt Service Ratios
- - -
Payout Ratios
- - -

Quarterly Metrics And Ratios for LGN

This table displays calculated financial ratios and metrics derived from LGN's official financial filings.

Metric Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
0.00 0.00 0.00 0.00 108,037,932.00 108,037,932.00 108,075,480.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00 0.00 108,037,932.00 108,037,932.00 108,075,480.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00 0.00 0.15 -0.26 0.83
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 26.25% 105.14% 110.74% 85.12%
EBITDA Growth
0.00% 0.00% 0.00% 16.92% 41.10% -40.58% 223.48%
EBIT Growth
0.00% 0.00% 0.00% 37.62% 42.86% -127.63% 349.94%
NOPAT Growth
0.00% 0.00% 0.00% 167.50% 736.64% 93.43% 4,503.49%
Net Income Growth
0.00% 0.00% 0.00% 156.07% 190.88% -793.36% 35,223.75%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% 307.70% 124.85% -17.17%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 90.86%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.96%
Revenue Q/Q Growth
0.00% 0.00% 18.37% 0.00% 0.00% 21.60% 3.85%
EBITDA Q/Q Growth
0.00% 0.00% 37.28% 0.00% 0.00% -42.19% 489.05%
EBIT Q/Q Growth
0.00% 0.00% 124.54% 0.00% 0.00% -143.42% 2,060.37%
NOPAT Q/Q Growth
0.00% 0.00% -716.50% 0.00% 0.00% -104.84% 3,201.92%
Net Income Q/Q Growth
0.00% 0.00% 79.78% 0.00% 0.00% -298.71% 487.33%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% -384.62% 410.81%
Operating Cash Flow Q/Q Growth
0.00% 387.85% 12.29% 0.00% 26.77% -38.07% 10.90%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% -5.39% 92.17%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% -0.77% 2.38%
Profitability Metrics
- - - - - - -
Gross Margin
21.14% 22.08% 21.49% 20.91% 17.94% 17.45% 21.02%
EBITDA Margin
9.37% 8.74% 10.14% 8.68% 6.01% 2.86% 16.21%
Operating Margin
4.81% 3.27% 5.17% 5.25% 2.16% -0.53% 12.75%
EBIT Margin
4.83% 2.72% 5.17% 5.26% 1.90% -0.68% 12.79%
Profit (Net Income) Margin
-0.12% -3.78% -0.65% 0.05% 1.68% -2.74% 10.21%
Tax Burden Percent
-17.39% 126.74% -230.71% 8.50% 433.44% 147.25% 87.13%
Interest Burden Percent
14.36% -109.55% 5.42% 11.96% 20.38% 274.51% 91.67%
Effective Tax Rate
117.39% 0.00% 330.71% 91.50% -333.44% 0.00% 12.87%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 33.22% -1.62% 29.81%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 12.88% -9.66% 28.06%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 10.60% -7.34% 19.82%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00% 43.82% -8.96% 49.63%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 1.68% -0.68% 17.29%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 1.48% -2.74% 13.81%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00% 23.29% -5.50% 17.83%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-4.69 12 -71 3.16 97 -4.69 146
NOPAT Margin
-0.84% 2.29% -11.93% 0.45% 9.34% -0.37% 11.11%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.85% 20.33% 8.05% 1.75%
Return On Investment Capital (ROIC_SIMPLE)
- - - 0.19% 4.90% -0.23% 6.93%
Cost of Revenue to Revenue
78.86% 77.92% 78.51% 79.09% 82.06% 82.55% 78.98%
SG&A Expenses to Revenue
11.98% 13.73% 12.10% 12.13% 11.19% 11.69% 5.38%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
16.55% 18.90% 16.32% 15.66% 15.83% 17.98% 8.28%
Earnings before Interest and Taxes (EBIT)
27 14 31 37 20 -8.55 168
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
53 44 61 61 62 36 212
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 12.11 10.79 6.12
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 1.99 1.73 0.96
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 92.60
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.08%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 4.24 4.42 2.98
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 2.38 2.03 1.21
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 39.79 47.47 17.12
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 134.35 499.89 36.10
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 155.80 365.26 46.71
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 21.15 19.55 14.14
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.00 0.00 1.00 1.08 1.06 0.96
Long-Term Debt to Equity
0.00 0.00 0.00 0.98 1.06 1.03 0.94
Financial Leverage
0.00 0.00 0.00 0.79 0.82 0.76 0.71
Leverage Ratio
0.00 0.00 0.00 3.14 3.66 3.83 3.39
Compound Leverage Factor
0.00 0.00 0.00 0.38 0.75 10.50 3.10
Debt to Total Capital
0.00% 0.00% 0.00% 50.04% 51.92% 51.42% 48.99%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.98% 0.93% 1.30% 1.06%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 49.06% 51.00% 50.11% 47.93%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 26.54% 22.53% 18.74% 18.53%
Common Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 25.55% 29.84% 32.47%
Debt to EBITDA
0.00 0.00 0.00 0.00 5.56 6.46 3.36
Net Debt to EBITDA
0.00 0.00 0.00 0.00 4.24 4.64 2.24
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 5.46 6.30 3.28
Debt to NOPAT
0.00 0.00 0.00 0.00 21.77 49.72 9.15
Net Debt to NOPAT
0.00 0.00 0.00 0.00 16.59 35.69 6.12
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 21.38 48.46 8.95
Altman Z-Score
0.00 0.00 0.00 0.00 2.35 2.42 2.27
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 46.85% 38.57% 64.07%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 0.00 0.00 1.57 1.30 1.35 1.44
Quick Ratio
0.00 0.00 0.00 1.16 0.95 0.99 0.97
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 -1,477 -1,637 -1,725 -135
Operating Cash Flow to CapEx
0.00% 556.18% 380.20% 0.00% 679.02% 310.47% 452.98%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 -43.62 -96.27 -101.91 -8.20
Operating Cash Flow to Interest Expense
0.00 0.99 1.09 0.00 7.07 4.40 5.01
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.82 0.80 0.00 6.02 2.98 3.90
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.89 1.00 1.35
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 3.73 4.08 6.08
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 7.06 7.10 10.59
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 97.96 89.55 60.02
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 51.72 51.44 34.46
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 46.23 38.10 25.55
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 0.00 0.00 1,480 1,733 1,720 1,761
Invested Capital Turnover
0.00 0.00 0.00 0.00 3.56 4.36 2.68
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 1,480 1,733 1,720 281
Enterprise Value (EV)
0.00 0.00 0.00 0.00 7,350 7,600 5,255
Market Capitalization
728 728 728 0.00 6,122 6,480 4,177
Book Value per Share
$0.00 $0.00 $0.00 $0.00 $4.68 $5.56 $6.31
Tangible Book Value per Share
$0.00 $0.00 $0.00 ($12.77) ($10.92) ($9.39) ($8.32)
Total Capital
0.00 0.00 0.00 1,656 1,978 2,012 2,102
Total Debt
0.00 0.00 0.00 829 1,027 1,035 1,030
Total Long-Term Debt
0.00 0.00 0.00 813 1,009 1,008 1,007
Net Debt
0.00 0.00 0.00 653 782 743 689
Capital Expenditures (CapEx)
0.00 5.30 8.70 0.00 18 24 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 218 111 158 220
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 394 355 450 561
Net Working Capital (NWC)
0.00 0.00 0.00 378 337 424 538
Net Nonoperating Expense (NNE)
-4.01 31 -68 2.78 80 30 12
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 653 782 743 689
Total Depreciation and Amortization (D&A)
25 30 30 24 43 45 45
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 3.60% 4.21% 5.06%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 11.53% 12.01% 12.89%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 10.94% 11.31% 12.38%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.24 ($0.37) $1.16
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 0.00 67.15M 76.03M 76.93M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.13 ($0.37) $1.15
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 0.00 108.43M 76.03M 77.81M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 105.34M 108.04M 108.08M 108.53M
Normalized Net Operating Profit after Tax (NOPAT)
19 12 22 27 24 24 146
Normalized NOPAT Margin
3.38% 2.30% 3.61% 3.76% 2.28% 1.92% 11.14%
Pre Tax Income Margin
0.69% -2.98% 0.28% 0.63% 0.39% -1.86% 11.72%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
1.14 0.47 1.02 1.10 1.16 -0.51 10.17
NOPAT to Interest Expense
-0.20 0.39 -2.35 0.09 5.70 -0.28 8.84
EBIT Less CapEx to Interest Expense
0.00 0.29 0.73 0.00 0.12 -1.92 9.07
NOPAT Less CapEx to Interest Expense
0.00 0.21 -2.64 0.00 4.66 -1.69 7.73
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.35%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -50.99% -15.72% 20.70%

Financials Breakdown Chart

Key Financial Trends

LGN’s second-quarter results show strong top-line growth but weaker profitability. Revenue rose to $1.26 billion in Q2 2026, up 21.6% from Q1 2026 and more than double the $598.9 million reported in Q2 2025. However, rising operating expenses, a $41.1 million impairment charge and higher depreciation pushed the company to a $6.7 million operating loss, compared with operating income of $22.4 million in Q1.

Gross profit increased to $220.2 million, but the gross margin narrowed to approximately 17.5% from 17.9% in Q1 and 21.5% in Q2 2025. Net loss attributable to common shareholders was $27.8 million, or $0.37 per diluted share, reversing Q1’s $16.1 million profit. The company has reported losses attributable to common shareholders in several recent quarters, including Q1 and Q2 2025.

Cash generation remains a relative strength. Q2 operating cash flow was $74.4 million, although that was down from $120.1 million in Q1. Cash and equivalents increased to $292.0 million from $244.6 million at the end of Q1, helped by positive operating cash flow despite $24.0 million of capital expenditures and modest debt repayments.

The balance sheet has expanded significantly, with total assets reaching $3.74 billion from $2.60 billion in Q3 2025. Much of that growth is tied to acquisitions and acquired goodwill and intangible assets. Total debt was approximately $1.03 billion, while retained earnings remained negative at $321.7 million. Accounts receivable also increased to $918.9 million, creating an important working-capital and collection risk as the business grows.

  • Rapid revenue growth: Q2 revenue increased 21.6% sequentially and approximately 111% year over year, indicating continued expansion in the company’s operating base.
  • Positive operating cash flow: LGN generated $74.4 million of operating cash flow in Q2 and $194.5 million during the first half of 2026.
  • Improved cash position: Cash and equivalents increased to $292.0 million at June 30, 2026, providing liquidity for operations and debt obligations.
  • Current liquidity is adequate: Current assets of $1.65 billion exceeded current liabilities of $1.22 billion, implying a current ratio of roughly 1.35.
  • Acquisition-led expansion: First-quarter acquisition spending totaled $281.3 million, and total assets have grown substantially. This could support future revenue, but integration and return-on-investment outcomes remain important to monitor.
  • Cash flow benefits from noncash expenses: Q2 operating cash flow was supported by $33.8 million of amortization and $92.9 million of other noncash adjustments, meaning reported cash generation was meaningfully higher than net income.
  • Profitability deteriorated: LGN moved from $22.4 million of operating income in Q1 to a $6.7 million operating loss in Q2, while gross margin declined year over year.
  • Common shareholders absorbed another loss: Q2 net loss attributable to common shareholders was $27.8 million, or $0.37 per diluted share, following a profitable Q1.
  • High leverage and interest burden: Total debt was approximately $1.03 billion, and Q2 interest expense was $16.9 million, exceeding interest and investment income by $14.9 million.
  • Working-capital and asset-quality risks: Accounts receivable rose to $918.9 million, while goodwill and intangible assets totaled approximately $1.61 billion. The Q2 impairment charge highlights the risk of future write-downs if acquired assets underperform.
11/18/26 05:51 AM ETAI Generated. May Contain Errors.

LGN Financials - Frequently Asked Questions

According to the most recent income statement we have on file, LGN's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

LGN's net income appears to be on a downward trend, with a most recent value of -$77.30 million in 2025, falling from -$46.03 million in 2023. The previous period was -$27.64 million in 2024. Check out LGN's forecast to explore projected trends and price targets.

LGN's total operating income in 2025 was $61.58 million, based on the following breakdown:
  • Total Gross Profit: $535.93 million
  • Total Operating Expenses: $475.79 million

Over the last 2 years, LGN's total revenue changed from $1.62 billion in 2023 to $2.55 billion in 2025, a change of 57.9%.

In the past 4 quarters, LGN's cash and equivalents has ranged from $176.03 million in Q3 2025 to $340.78 million in Q3 2026, and is currently $340.78 million as of their latest financial filing in Q3 2026.

LGN had total debt of $829.09 million at the end of 2025, a 48.5% decrease from 2024, and none in 2023.

Over the last 2 years, LGN's book value per share changed from 0.00 in 2023 to 0.00 in 2025, a change of 0.0%.



Financial statements for NASDAQ:LGN last updated on 11/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners